Priorities

null
F.D.A. Approves Pill to Treat Hepatitis C

F.D.A. Approves Pill to Treat Hepatitis C

by The Daily Eye Team December 10 2013, 3:30 pm Estimated Reading Time: 0 mins, 10 secs

The Food and Drug Administration has approved Sovaldi, from Gilead Sciences, which will let some patients be treated for a minimum of 12 weeks, but at a cost of $1,000 per daily pill. Click here to know more



About Author


User avatar

The Daily Eye Team


The Daily Eye Team has compiled an assemblage of links to further our continual and avowed objectives of promoting the betterment of our society.


Disclaimer: The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of thedailyeye.info. The writers are solely responsible for any claims arising out of the contents of this article.